2-O-Methyl-D-glucose | 4132-40-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2-O-Methyl-D-glucose
• 英文别名: O²-methyl-D-glucose；D-gluco-3,4,5,6-Tetrahydroxy-2-methoxy-hexanal；D-gluco-3,4,5,6-Tetrahydroxy-2-methoxy-hexanal; O²-Methyl-β-D-glucopyranose；α-Methyl-glucose；2-O-Methyl-glucose；(2R,3S,4R,5R)-3,4,5,6-tetrahydroxy-2-methoxyhexanal
• CAS: 4132-40-5
• 化学式: C₇H₁₄O₆
• 分子量: 194.185
• InChiKey: QRAXLHLYZJCAKB-XZBKPIIZSA-N

物化性质

• 熔点：
  158 °C
• 沸点：
  467.0±45.0 °C(Predicted)
• 密度：
  1.394±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -2.9
• 重原子数：
  13
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  107
• 氢给体数：
  4
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2-O-Methyl-D-glucose 在 sodium hydroxide 作用下， 生成 (Z)-D-erythro-4,5,6-trihydroxy-2-methoxy-hex-2-enal
  参考文献：
  名称：

  Klemer et al., 1965, vol. 1430, p. 40,41

  摘要：

  DOI：
• 作为产物：
  描述：

  1,2-O-异亚丙基-D-呋喃葡萄糖 在 盐酸 、 甲醇 、 氢氧化钾 作用下， 生成 2-O-Methyl-D-glucose
  参考文献：
  名称：

  Weygand; Trauth, Chemische Berichte, 1952, vol. 85, p. 57,59,60

  摘要：

  DOI：

文献信息

• [EN] PHENOTHIAZINE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE PHÉNOTHIAZINE ET LEURS UTILISATIONS
  申请人：CAMP4 THERAPEUTICS CORP

  公开号：WO2019195789A1

  公开（公告）日：2019-10-10

  The present invention provides phenothiazine compounds, processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment of various diseases or conditions, for example ribosomal disorders and ribosomopathies, e.g. Diamond Blackfan anemia (DBA).

  本发明提供了吩噻嗪化合物，其制备方法，包含该化合物的药物组合物，以及在治疗各种疾病或症状中使用该化合物或组合物，例如核糖体紊乱和核糖体病，例如钻石-布莱克范贫血（DBA）。
• [EN] ANTHRACENYL - TETRALACTAM MACROCYCLES AND THEIR USE IN DETECTING A TARGET SACCHARIDE<br/>[FR] MACROCYCLES ANTHRACÉNYLE-TÉTRALACTAME ET LEUR UTILISATION DANS LA DÉTECTION D'UN SACCHARIDE CIBLE
  申请人：UNIV BRISTOL

  公开号：WO2013160701A1

  公开（公告）日：2013-10-31

  A water-soluble compound of the formula (I): (Formula (I)) wherein R9 and R10 are suitably hydrophilic substituents, which may be used to selectively bind to a target saccharide such as glucose and which exhibits a detectable spectroscopic response to such binding, thus enabling its use in the detection and correction of blood glucose concentrations in vivo.

  一种水溶性化合物的化学式（I）：（化学式（I）），其中R9和R10是适当亲水性取代基，可用于选择性地结合到葡萄糖等靶标糖，并且对此类结合表现出可检测的光谱响应，从而使其能够用于体内检测和校正血糖浓度。
• ANTHRACENYL-TETRALACTAM MACROCYCLES AND THEIR USE IN DETECTING A TARGET SACCHARIDE
  申请人：UNIVERSITY OF BRISTOL

  公开号：US20150147275A1

  公开（公告）日：2015-05-28

  A water-soluble compound of the formula (I): (Formula (I)) wherein R 9 and R 10 are suitably hydrophilic substituents, which may be used to selectively bind to a target saccharide such as glucose and which exhibits a detectable spectroscopic response to such binding, thus enabling its use in the detection and correction of blood glucose concentrations in vivo.

  化学式（I）的水溶性化合物：（化学式（I）），其中R9和R10是适当亲水性取代基，可用于选择性地结合到目标糖类，如葡萄糖，并且对此结合表现出可检测的光谱响应，从而使其能够用于体内检测和校正血糖浓度。
• [EN] BINDING-SITE MODIFIED LECTINS AND USES THEREOF<br/>[FR] LECTINES DE SITE DE LIAISON MODIFIÉES ET USAGE CORRESPONDANT
  申请人：SMARTCELLS INC

  公开号：WO2010088261A1

  公开（公告）日：2010-08-05

  In one aspect, the disclosure provides cross-linked materials that include multivalent lectins with at least two binding sites for glucose, wherein the lectins include at least one covalently linked affinity ligand which is capable of competing with glucose for binding with at least one of said binding sites; and conjugates that include two or more separate affinity ligands bound to a conjugate framework, wherein the two or more affinity ligands compete with glucose for binding with the lectins at said binding sites and wherein conjugates are cross-linked within the material as a result of non-covalent interactions between lectins and affinity ligands on different conjugates. These materials are designed to release amounts of conjugate in response to desired concentrations of glucose. Depending on the end application, in various embodiments, the conjugates may also include a drug and/or a detectable label.

  在一个方面，该公开提供了包括多价凝集素的交联材料，其中该多价凝集素具有至少两个葡萄糖结合位点，其中该凝集素包括至少一个与亲和配体共价连接的亲和配体，该亲和配体能够与至少一个所述结合位点中的葡萄糖竞争结合；以及包括绑定到共轭框架的两个或更多个独立亲和配体的共轭物，其中这两个或更多个亲和配体与葡萄糖在所述结合位点上与凝集素竞争结合，其中由于不同共轭物上的凝集素和亲和配体之间的非共价相互作用，共轭物在材料内交联。这些材料旨在根据所需葡萄糖浓度释放共轭物的量。根据最终应用，在各种实施例中，共轭物还可以包括药物和/或可检测标记。
• [EN] GLUCOSE-RESPONSIVE INSULIN CONJUGATES<br/>[FR] CONJUGUÉS D'INSULINE SENSIBLES AU GLUCOSE
  申请人：MERCK SHARP & DOHME

  公开号：WO2021021535A1

  公开（公告）日：2021-02-04

  Glucose-responsive insulin conjugates that contain one or more trisaccharides are provided. Such insulin conjugates may display a pharmacokinetic (PK) and/or pharmacodynamic (PD) profile that is responsive to the systemic concentrations of a saccharide such as glucose or alpha-methylmannose, even when administered to a subject in need thereof in the absence of an exogenous multivalent saccharide-binding molecule.

  提供含有一种或多种三糖的对葡萄糖反应的胰岛素结合物。这样的胰岛素结合物可能显示出对葡萄糖或α-甲基甘露糖等糖类的全身浓度有响应的药代动力学（PK）和/或药效学（PD）特征，即使在没有外源性多价糖类结合分子的存在下，给予需要它的受试者。